Brickell Biotech Inc reports results for the quarter ended in March - Earnings Summary

Fresh Tracks Therapeutics

12/05/2022 22:02

* Brickell Biotech Inc  BBI.OQ  reported a quarterly
adjusted loss
of 8 cents​​ per share for the quarter ended in March. The mean
expectation of four analysts for the quarter was for a loss of 6
cents per share.
    * Revenue rose 441.2% to $92.00 thousand from a year ago; 
analysts expected $143.75 thousand. 
    * The mean earnings estimate of analysts had risen by
about 36.1%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Brickell Biotech Inc shares had fallen by 25.2% this
quarter and
lost 12.6% so far this year.
    * Wall Street's median 12-month price target for Brickell
Biotech
Inc is $2.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated May 12 at 09:01 p.m.  ​All
figures in US dollars unless otherwise stated